Cargando…
Late stage inhibition of hematogenous melanoma metastasis by cystatin C over-expression
BACKGROUND: Tumor metastasis is a frequent cause of treatment failure for cancer patients. A key feature of metastatic cancer cells is their invasive ability. Cysteine proteases contribute to invasive properties of many cancer cell types. To analyze the contribution of cysteine proteases to metastas...
Autores principales: | Ervin, Heather, Cox, James L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1156918/ https://www.ncbi.nlm.nih.gov/pubmed/15904519 http://dx.doi.org/10.1186/1475-2867-5-14 |
Ejemplares similares
-
A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis
por: Li, Man, et al.
Publicado: (2010) -
Significance of lymph node metastasis in the survival of stage IV colorectal cancer by hematogenous metastasis
por: Han, Eon Chul, et al.
Publicado: (2018) -
Platelet GPIIb supports initial pulmonary retention but inhibits subsequent proliferation of melanoma cells during hematogenic metastasis
por: Echtler, Katrin, et al.
Publicado: (2017) -
Hematogenous Gastric Metastasis of Pancreatic Cancer
por: Sasajima, Junpei, et al.
Publicado: (2016) -
Clinicopathologic characteristics and survival analysis in stage IVB cervical cancer with hematogenous metastasis
por: Li, Haoran, et al.
Publicado: (2019)